Standard BioTools
Standard BioTools Inc., a California-based medical organization, provides technologies for biomedical research to improve patient outcomes.
Founded
1999Standard BioTools Inc., a California-based medical organization, provides technologies for biomedical research to improve patient outcomes.
Standard BioTools Inc., founded in South San Francisco, California, is dedicated to advancing biomedical research through innovative technologies. The company's core mission is to provide reliable and repeatable insights into health and disease, thereby transforming scientific discoveries into improved patient outcomes. Standard BioTools specializes in proprietary mass cytometry and microfluidics technologies, offering solutions such as the CyTOF XT™ mass cytometer for functional profiling in spectral flow cytometry. Their market focus is on biomedical researchers and institutions aiming to develop new medicines and therapeutic approaches.
Notable affiliated individuals include Jennifer Snyder-Cappione, PhD, an Assistant Professor at Boston University School of Medicine, who has been involved in key research sessions. The company has garnered attention for its significant contributions to spatial biology and intracellular staining techniques. Standard BioTools' technologies have had a substantial impact on the biomedical field by enabling more precise and comprehensive research, ultimately contributing to better patient outcomes and advancing the development of new medical treatments.
Companies similar to Standard BioTools include Fluidigm, Teiko.bio, BioFluidica and Bio-Rad.
Standard BioTools was founded in 1999.
Standard BioTools' headquarters is located in South San Francisco, CA, US.
Standard BioTools' most recent funding round was for $250M (USD) in January 2022.
As of Jan 24, 2022, Standard BioTools has raised a total of $375.2M (USD).
Standard BioTools has 523 employees as of Feb 5, 2024.
BioFluidica
biofluidica.com
